EARSWITCH LTD

Active Manchester

Research and experimental development on biotechnology

12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EARSWITCH LTD

Research and experimental development on biotechnology

Founded 11 Dec 2019 Active Manchester, England 12 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 26 Jan 2026 Next due 30 Sept 2027 17 months remaining
Confirmation Submitted 2 Jan 2026 Next due 24 Dec 2026 7 months remaining
Net assets £94K £352K 2025 year on year
Total assets £441K £150K 2025 year on year
Total Liabilities £347K £202K 2025 year on year
Charges 3
2 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

111 Piccadilly Manchester M1 2HY England

Website

www.example.com

Full company profile for EARSWITCH LTD (12358776), an active life sciences and medical technology company based in Manchester, England. Incorporated 11 Dec 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2020–2025)

Cash in Bank

£80.82k

Decreased by £87.33k (-52%)

Net Assets

£93.62k

Decreased by £351.65k (-79%)

Total Liabilities

£347.33k

Increased by £201.62k (+138%)

Turnover

N/A

Employees

12

Decreased by 2 (-14%)

Debt Ratio

79%

Increased by 54 (+216%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 6May 2023Seed
Investor 7May 2023Seed
Investor 8May 2023Seed

Share Capital

Share Capital

Share allotments and capital structure

16 Allotments 66,614 Shares £15.33m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
11 Dec 20251,000£40k£40
10 Dec 2025500£20k£40
4 Dec 20251,000£40k£40
4 Apr 2025722£17k£23.7
28 Feb 2025633£15k£23.7

Officers

Officers

3 active
Status
Dominic John KeenDirectorBritishUnited Kingdom4917 Oct 2022Active
Gai Rosemary BennettDirectorBritishEngland5620 Feb 2024Active
Nicholas Roy GompertzDirectorBritishUnited Kingdom5811 Dec 2019Active

Shareholders

Shareholders (25)

Nicholas Roy Gompertz
58.8%
100,200
Gmc Life Sciences Fund
19.8%
33,755

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Nicholas Roy Gompertz

British

Active
Notified 11 Dec 2019
Residence United Kingdom
DOB July 1967
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Apr 2026ResolutionResolutions
26 Jan 2026AccountsAnnual accounts made up to 31 Dec 2025
2 Jan 2026Confirmation StatementConfirmation statement made on 10 Dec 2025 with updates
20 Dec 2025ResolutionResolutions
11 Dec 2025CapitalAllotment of shares (GBP 1.71529) on 11 Dec 2025
22 Apr 2026 Resolution

Resolutions

26 Jan 2026 Accounts

Annual accounts made up to 31 Dec 2025

2 Jan 2026 Confirmation Statement

Confirmation statement made on 10 Dec 2025 with updates

20 Dec 2025 Resolution

Resolutions

11 Dec 2025 Capital

Allotment of shares (GBP 1.71529) on 11 Dec 2025

Recent Activity

Latest Activity

Resolutions

1 weeks ago on 22 Apr 2026

Annual accounts made up to 31 Dec 2025

3 months ago on 26 Jan 2026

Confirmation statement made on 10 Dec 2025 with updates

3 months ago on 2 Jan 2026

Resolutions

4 months ago on 20 Dec 2025

Allotment of shares (GBP 1.71529) on 11 Dec 2025

4 months ago on 11 Dec 2025